ProShare Advisors
KYMR icon

ProShare Advisors’s Kymera Therapeutics KYMR Stock Holding History

ProShare Advisors’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25M Sell
10,900
-1,062
-9% -$91.2K ﹤0.01% 748
2026
Q1 		$996K Sell
11,962
-1,527
-11% -$121K ﹤0.01% 790
2025
Q4 		$1.05M Buy
13,489
+2,320
+21% +$157K ﹤0.01% 807
2025
Q3 		$632K Sell
11,169
-860
-7% -$38.8K ﹤0.01% 989
2025
Q2 		$525K Sell
12,029
-1,067
-8% -$36.7K ﹤0.01% 1099
2025
Q1 		$358K Sell
13,096
-3,197
-20% -$117K ﹤0.01% 1293
2024
Q4 		$655K Buy
16,293
+4,071
+33% +$184K ﹤0.01% 1122
2024
Q3 		$578K Buy
12,222
+2,972
+32% +$131K ﹤0.01% 1059
2024
Q2 		$276K Sell
9,250
-2,359
-20% -$81.7K ﹤0.01% 1345
2024
Q1 		$467K Buy
11,609
+1,775
+18% +$63.5K ﹤0.01% 1134
2023
Q4 		$250K Buy
+9,834
New +$176K ﹤0.01% 1506
2023
Q2 		– Sell
-8,276
Closed -$245K – 1879
2023
Q1 		$245K Sell
8,276
-1,121
-12% -$36.2K ﹤0.01% 1324
2022
Q4 		$235K Buy
+9,397
New +$251K ﹤0.01% 1383
2022
Q2 		– Sell
-11,790
Closed -$499K – 1969
2022
Q1 		$499K Sell
11,790
-2,953
-20% -$125K ﹤0.01% 1276
2021
Q4 		$935K Buy
14,743
+10,338
+235% +$602K ﹤0.01% 1060
2021
Q3 		$259K Sell
4,405
-3,094
-41% -$179K ﹤0.01% 1651
2021
Q2 		$364K Buy
+7,499
New +$326K ﹤0.01% 1760

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

ProShare Advisors's KYMR Position: Q2 2026 in Review

ProShare Advisors reduced its Kymera Therapeutics (KYMR) stake by 8.9% in Q2 2026, selling an estimated $91.2K and leaving 10,900 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #748.

ProShare Advisors first reported a position in KYMR in Q2 2021 and has held it in 17 quarters since. 275 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • ProShare Advisors held 10,900 shares of Kymera Therapeutics worth $1.25M as of Q2 2026.
  • ProShare Advisors sold 1,062 Kymera Therapeutics shares in Q2 2026, an estimated $91.2K.
  • Kymera Therapeutics made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #748 holding.
  • ProShare Advisors first reported a position in Kymera Therapeutics in Q2 2021 and has held it in 17 quarters since.
  • 275 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.